Literature DB >> 26070245

The intra-tumoral relationship between microcirculation, interstitial fluid pressure and liposome accumulation.

Shawn Stapleton1, Michael Milosevic2, Ian F Tannock3, Christine Allen4, David A Jaffray5.   

Abstract

The heterogeneous intra-tumoral accumulation of liposomes has been linked to both the chaotic tumor microcirculation and to elevated interstitial fluid pressure (IFP). Here, we explored the relationship between tumor microcirculation, IFP, and the intra-tumoral accumulation of liposomes. Measurements of the tumor microcirculation using perfusion imaging, IFP using a novel image-guided robotic needle positioning system, and the intra-tumoral distribution of liposomes using volumetric micro-CT imaging were performed in mice bearing subcutaneous and orthotopic MDA-MB-231 tumors. Intra-tumoral perfusion and IFP were substantially different between the two tumor implantation sites. Tumor perfusion and not vascular permeability was found to be the primary mediator of the intra-tumoral accumulation of CT-liposomes. A strong relationship was observed between the radial distribution of IFP, metrics of tumor perfusion, and the intra-tumoral accumulation of liposomes. Tumors with elevated central IFP that decreased at the periphery had low perfusion and low levels of CT-liposome accumulation that increased towards the periphery. Conversely, tumors with low and radially uniform IFP exhibited higher levels of tumor perfusion and CT-liposome accumulation. Both tumor perfusion and elevated IFP exhibit substantial intra-tumoral heterogeneity and both play an integral role in mediating the intra-tumoral accumulation of liposomes through a complex interactive effect. Measuring IFP in the clinical setting remains challenging and these results demonstrate that tumor perfusion imaging alone provides a robust non-invasive method to identify factors that contribute to poor liposome accumulation and may allow for pre-selection of patients that are more likely to respond to nanoparticle therapy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Blood flow; Drug delivery; Interstitial fluid pressure; Intra-tumoral heterogeneity; Liposomes; Nanomedicine; Transport

Mesh:

Substances:

Year:  2015        PMID: 26070245     DOI: 10.1016/j.jconrel.2015.06.008

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  24 in total

Review 1.  Systemic Bioequivalence Is Unlikely to Equal Target Site Bioequivalence for Nanotechnology Oncologic Products.

Authors:  Jessie L-S Au; Ze Lu; Roberto A Abbiati; M Guillaume Wientjes
Journal:  AAPS J       Date:  2019-02-01       Impact factor: 4.009

2.  Spatial Measurements of Perfusion, Interstitial Fluid Pressure and Liposomes Accumulation in Solid Tumors.

Authors:  Shawn Stapleton; Daniel Mirmilshteyn; Jinzi Zheng; Christine Allen; David A Jaffray
Journal:  J Vis Exp       Date:  2016-08-18       Impact factor: 1.355

Review 3.  Strategies for improving the intratumoral distribution of liposomal drugs in cancer therapy.

Authors:  Beth Goins; William T Phillips; Ande Bao
Journal:  Expert Opin Drug Deliv       Date:  2016-04-04       Impact factor: 6.648

Review 4.  Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.

Authors:  Andrew T Lucas; Lauren Sl Price; Allison Schorzman; William C Zamboni
Journal:  Nanomedicine (Lond)       Date:  2017-07-26       Impact factor: 5.307

5.  Radiation therapy primes tumors for nanotherapeutic delivery via macrophage-mediated vascular bursts.

Authors:  Miles A Miller; Ravi Chandra; Michael F Cuccarese; Christina Pfirschke; Camilla Engblom; Shawn Stapleton; Utsarga Adhikary; Rainer H Kohler; James F Mohan; Mikael J Pittet; Ralph Weissleder
Journal:  Sci Transl Med       Date:  2017-05-31       Impact factor: 17.956

6.  Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment.

Authors:  Oliver K Appelbe; Qingbei Zhang; Charles A Pelizzari; Ralph R Weichselbaum; Stephen J Kron
Journal:  Mol Pharm       Date:  2016-09-01       Impact factor: 4.939

Review 7.  Addressing challenges of heterogeneous tumor treatment through bispecific protein-mediated pretargeted drug delivery.

Authors:  Qi Yang; Christina L Parker; Justin D McCallen; Samuel K Lai
Journal:  J Control Release       Date:  2015-09-25       Impact factor: 9.776

8.  Histidine-rich glycoprotein-induced vascular normalization improves EPR-mediated drug targeting to and into tumors.

Authors:  Benjamin Theek; Maike Baues; Felix Gremse; Robert Pola; Michal Pechar; Inka Negwer; Kaloian Koynov; Benjamin Weber; Matthias Barz; Willi Jahnen-Dechent; Gert Storm; Fabian Kiessling; Twan Lammers
Journal:  J Control Release       Date:  2018-05-04       Impact factor: 9.776

Review 9.  Enhancing Tumor Penetration of Nanomedicines.

Authors:  Qingxue Sun; Tarun Ojha; Fabian Kiessling; Twan Lammers; Yang Shi
Journal:  Biomacromolecules       Date:  2017-03-31       Impact factor: 6.988

Review 10.  Recent progress in nanomedicine for enhanced cancer chemotherapy.

Authors:  Guoqing Wei; Yu Wang; Guang Yang; Yi Wang; Rong Ju
Journal:  Theranostics       Date:  2021-04-19       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.